What Wecare does

Wecare (legally Wecare Comércio de Cosméticos Ltda - ME) is a Brazilian dermatological products company founded in 2016 and headquartered at Rua Fábia 959, Vila Romana, São Paulo. The company develops and sells skincare formulations specifically engineered for oncology patients undergoing chemotherapy and radiotherapy, addressing dermatological and mucosal side effects such as xerose cutânea (dryness), rash cutâneo, radiodermite, hand-foot syndrome, and oral mucositis.

The product portfolio comprises six core SKUs — Washcare (cleansing foam), Moistcare (moisturizing lotion, 100ml and 192ml formats), Extremecare (super-moisturizer, 60g and 120g formats), Coolcare Mask, Oralcare Gel, and Oralcare Enxaguatório (oral rinse) — plus five condition-specific kits. All formulations exclude parabens, waxes, fragrances, colorants, and urea, and feature a proprietary active ingredient, Thoitaine (Ergothioneine), a biotechnologically extracted amino acid with antioxidant properties. The company cites over a decade of R&D supported by Brazilian research agencies FAPESC and FINEP, and claims to be the only Brazilian skincare line with clinical studies conducted specifically in cancer patients, reporting 80,000+ patients impacted and inclusion in the Manual de Oncologia Clínica do Brasil (MOC).

Wecare operates a multi-channel go-to-market model: direct e-commerce via wecareskin.com with phone and WhatsApp ordering; retail distribution through the RD Saúde pharmacy chain (Drogasil, Droga Raia) and oncology specialty retailer Oncoshop; hospital channel sales including standardization at Hospital Israelita Albert Einstein, ICESP, and Hospital de Amor de Barretos; and B2B enterprise partnerships with major pharmaceutical companies (Amgen, Novartis, Libbs) that distribute Wecare products through patient support programs. Individual SKUs are priced between R$96.72 and R$179.92, kits range from R$225 to R$599, and progressive volume discounts are available. The company is privately held, operates with 1–10 employees, and has received at least one disclosed venture investment from Eretz.bio.

Name

Wecare

Legal name

Wecare Comércio de Cosméticos Ltda - ME

Website

https://wecareskin.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

Wecare is a Brazilian dermatological company, founded in 2016 and based in São Paulo, that develops and sells oncology-specific skincare formulations for patients undergoing chemotherapy and radiotherapy, distributed through hospitals, pharmacy chains, pharma patient support programs, and direct e-commerce.

Ownership category

akta.pro rank

Product category

Oncology Skincare Products

NAICS

Cosmetics, Beauty Supplies, and Perfume Retailers (456120)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Treatment Skincare (Serums, Actives, Acne & Anti-aging) (CRABAAAB)

akta.pro secondary industries

Dermocosmetics & Medical-Grade Skincare (CRABAAAF), Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF)

Keywords

• Oncology skincare products
• Chemotherapy skin care
• Radiotherapy dermatological care
• Oral mucositis treatment
• Medical cosmetics

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Marketing or Sales, Operations, Personnel

Revenue model

1. Direct product sales: E-commerce sales of skincare products directly to oncology patients and their caregivers through the company website.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels4 records

Core offering

Wecare develops, manufactures, and sells dermatological skincare and oral care products specifically formulated for oncology patients undergoing chemotherapy and radiotherapy. The product line addresses skin and mucosal complications including xerose cutânea, rash cutâneo, radiodermite, hand-foot syndrome, and oral mucositis. Products are sold directly to consumers via e-commerce, through pharmacy chains, oncology hospitals, and specialty oncology retailers, with clinical evidence supporting efficacy in cancer patient populations.

Product overview

Wecare is a Brazilian skincare product line specifically developed for oncology patients undergoing chemotherapy and radiotherapy. The product portfolio consists of six core products (Washcare, Moistcare, Extremecare, Coolcare Mask, Oralcare Gel, and Oralcare Enxaguatório) and five specialized kits for different treatment needs. The products are formulated without parabens, fragrances, dyes, or other aggressive ingredients, and are the only line in Brazil with clinical studies conducted specifically in cancer patients. The company has partnerships with major Brazilian cancer hospitals including Hospital Israelita Albert Einstein, ICESP, and Hospital de Amor de Barretos.

Differentiator

Problem solved

Functional benefit

Products and services

• Washcare Cleaning foam for sensitive, dry, or irritated skin during chemotherapy and radiotherapy, formulated with natural amino acids, Aloe Vera, and Calendula oil for gentle cleansing without stripping moisture. Targeted at oncology patients experiencing skin sensitivity.
• Moistcare Moisturizing lotion (100ml and 192ml sizes) for red, painful, and dry skin during chemotherapy and radiotherapy. Contains Hazelnut oil, Calendula, Shea butter, Aloe Vera, Chamomile, Oat, Vitamin E, and Thoitaine for deep hydration and skin recovery. Targeted at oncology patients with dermatological side effects.
• Extremecare Super-moisturizer (60g and 120g sizes) for extremely dry, peeling, or itchy skin caused by chemotherapy or radiotherapy. Formulated with Glycerin, Hazelnut oil, Calendula oil, Shea butter, Chamomile, Oat, Aloe Vera, Vitamin E, and Thoitaine. Targeted at oncology patients with severe skin dryness.
• Coolcare Mask Calming mask to relieve hot, burning, and sensitive skin sensation during radiotherapy. Provides immediate refreshing sensation and prolonged comfort with Aloe Vera, Calendula oil, and Frescolat. Targeted at radiotherapy patients experiencing radiodermite and burning.
• Oralcare Gel Oral gel for treatment of active oral mucosal lesions. Contains Demineralized Water, Glycerin, Hytellose, Glutamine, Xylitol, Sodium Benzoate, Potassium Sorbate, and Hydrolyzed Hyaluronic Acid. Targeted at oncology patients experiencing oral mucositis.
• Oralcare Enxaguatório Alcohol-free and dye-free oral rinse for prevention and care of oral mucositis. Contains L-Glutamine, Sodium Fluoride (1356.75 ppm fluoride), and Xylitol. Targeted at oncology patients at risk of oral mucosal complications.
• Kit Pele na Quimioterapia (Chemotherapy Skin Care Kit) Specialized kit for treatment and prevention of skin dryness in chemotherapy patients, including Washcare, Extremecare, and Moistcare for complete skin care. Targeted at chemotherapy patients at a bundled price (R$427.00).
• Kit Pele na Quimio e Rádio (Chemo and Radio Skin Care Kit) Comprehensive kit for care and prevention of side effects on skin from chemotherapy and radiotherapy, including Washcare, Extremecare, Moistcare, and Coolcare Mask. Targeted at patients undergoing both treatments (R$599.00).
• Kit Mãos e Pés Ressecados pela Quimio (Dry Hands and Feet Chemo Kit) Kit for treatment and prevention of dry hands and feet in cancer patients, addressing Hand-Foot Syndrome with Washcare and Extremecare. Targeted at chemotherapy patients experiencing hand-foot syndrome (R$279.00).
• Kit Rash Cutâneo (Cutaneous Rash Kit) Kit for care and prevention of cutaneous rash associated with chemotherapy, helping reduce irritation, sensitivity, and dermatological discomfort. Targeted at chemotherapy patients experiencing rash (R$279.00).
• Kit de Cuidados Orais (Oral Care Kit) Oral care kit for prevention and care of mucositis, oral sensitivity, and mucosal dryness, including Oralcare Gel and Oralcare Enxaguatório. Targeted at oncology patients with oral complications (R$225.00).
• Kit Pele na Radioterapia (Radiotherapy Skin Care Kit) Specialized kit for treatment and prevention of skin dryness in radiotherapy patients. Targeted at radiotherapy patients experiencing skin side effects (R$451.00).

Quantifiable outcome

• 100% of patients in clinical studies maintained their oncology treatment without interruptions or dose reductions
• +3 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Nine partnerships are on record, tiered core and major.

• Hospital Israelita Albert EinsteincoreStrategic or Co-development PartnerWecare is the only skincare line with standardized products at Hospital Israelita Albert Einstein, one of Brazil's most prestigious hospitals. Products are part of prescribed care protocols.
• Hospital de Amor (Barretos)coreStrategic or Co-development PartnerWecare is the only skincare line with standardized products at Hospital de Amor de Barretos. Products are included in prescribed care and patient support protocols.
• ICESP (Instituto do Câncer do Estado de São Paulo)coreStrategic or Co-development PartnerWecare products are present and prescribed at ICESP, part of the state cancer institute network in São Paulo.
• AmgenmajorGTM or Marketing PartnerProducts indicated and acquired by Amgen for patient support programs during cancer treatment.
• NovartismajorGTM or Marketing PartnerProducts indicated and acquired by Novartis for patient support programs during cancer treatment.
• LibbsmajorGTM or Marketing PartnerProducts indicated and acquired by Libbs for patient support programs during cancer treatment.
• RD Saúde (Drogasil, Droga Raia)majorChannel Partner/ Reseller/ DistributorMajor pharmacy chain distribution partnership covering Drogasil and Droga Raia retail locations throughout Brazil.
• OncoshopcoreChannel Partner/ Reseller/ DistributorSpecialty oncology retailer for direct patient access to Wecare products.
• Dr. Antonio Carlos BuzaidcoreOthersEditor of Manual de Oncologia Clínica do Brasil (MOC), serves as a key medical reference for the Wecare ecosystem.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Lindi Skin: Lindi Skin is a US-based skincare brand specifically formulated for oncology patients undergoing chemotherapy and radiotherapy. Directly comparable to Wecare in vertical specialization, product categories (cleansers, moisturizers, body products), and clinical-evidence-led positioning.

Emerging players

• Hope for Hair / 4 Thoughts (oncology skincare): Hope for Hair and similar niche oncology-supportive brands develop scalp and skin products targeted at cancer patients, including scalp care during chemo-induced hair loss. Comparable to Wecare in addressing dermatological side effects of cancer therapy, though narrower in product scope.

Broad incumbents

• La Roche-Posay: La Roche-Posay is a global dermocosmetic leader with a dedicated oncology-support skincare range. Comparable to Wecare through overlapping target population (sensitive/compromised skin) and medical-grade positioning, though it operates as a broad incumbent rather than a niche oncology specialist.
• Avène (Pierre Fabre): Avène offers dermatological skincare lines for sensitive skin with products often used during medical treatments. Comparable through its clinical, dermatology-led brand positioning and overlap with Wecare's sensitive-skin patient base.
• Eucerin (Beiersdorf): Eucerin is a medical skincare brand offering products for dry, compromised, and sensitive skin, including ranges positioned for skin barrier repair. Overlaps with Wecare's hydration and barrier-restoration use cases for oncology patients.
• Galderma: Galderma is a global dermatology-focused company offering prescription and consumer skincare. Comparable through its dermatological specialization and presence in sensitive-skin and skin-barrier categories relevant to oncology patients.
• CeraVe: CeraVe offers dermatologist-recommended skincare with ceramides for skin barrier repair. Comparable through its positioning for compromised skin and pharmacy-distribution model, overlapping with Wecare's go-to-market and ingredient philosophy.

Others

• Mylan/Viatris Oncology Support: Viatris (and similar generic/specialty pharma players) operate patient-support programs that bundle supportive care products alongside oncology therapeutics. Comparable to Wecare as a counterparty in pharma patient-support ecosystems, similar to Wecare's relationships with Amgen, Novartis, and Libbs.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@wecareskin/videos

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wecare